LogicBio Therapeutics, Inc.
Related Filers (41)
- Arix Bioscience plc (10)
- Chereau Frederic (9)
- Kay Mark A (9)
- Chen Leon (8)
- MOSCICKI RICHARD A (8)
- WYZGA MICHAEL S (8)
- Enyedy Mark J (7)
- Chimovits Erez (6)
- O'Connell Daniel P (6)
- Jaffe Matthias (5)
- ORBIMED ADVISORS LLC (5)
- Jones Cecilia (5)
- Karydas Daphne (5)
- Goater Jeff (5)
- Gruskin Daniel (5)
- Wilton Thomas (4)
- Kariv Tomer (4)
- Yoon Seokho Bryan (4)
- Chiang Kyle (4)
- Nacht Mariana (4)
- Kahn Susan (4)
- Falb Dean (3)
- Poole Sandra (3)
- Ioannidou Sofia (3)
- Huttner Kenneth (3)
- Arix Bioscience Holdings Ltd (3)
- OrbiMed Capital GP VI LLC (3)
- OrbiMed Advisors Israel II Ltd (3)
- OrbiMed Israel GP II, L.P. (3)
- ADAGE CAPITAL PARTNERS GP, L.L.C. (3)
- Nussbaum Ran (3)
- Paul Andrea (3)
- Andera Partners (3)
- ALEXION PHARMACEUTICALS, INC. (3)
- Barzel Adi (2)
- FRANKLIN RESOURCES INC (2)
- Beryl Capital Management LLC (2)
- OrbiMed Genesis GP LLC (1)
- Quick Jonathan (1)
- Blacher Joshua (1)
- Nasdaq Stock Market LLC (1)
- Show More ...
Financials (20)
10-Q
Monday, 11/14/2022
Quarterly Report for period ending 2022-09-30
10-Q
Monday, 8/15/2022
Quarterly Report for period ending 2022-06-30
10-Q
Monday, 5/16/2022
Quarterly Report for period ending 2022-03-31
10-K
Friday, 3/4/2022
Annual Report for period ending 2021-12-31
10-Q
Monday, 11/15/2021
Quarterly Report for period ending 2021-09-30
10-K/A
Friday, 11/5/2021
Annual Report for period ending 2020-12-31
10-Q
Monday, 8/9/2021
Quarterly Report for period ending 2021-06-30
10-Q
Monday, 5/10/2021
Quarterly Report for period ending 2021-03-31
10-K
Monday, 3/15/2021
Annual Report for period ending 2020-12-31
10-Q
Monday, 11/9/2020
Quarterly Report for period ending 2020-09-30
10-Q
Monday, 8/10/2020
Quarterly Report for period ending 2020-06-30
10-K/A
Friday, 6/5/2020
Annual Report for period ending 2019-12-31
10-Q/A
Friday, 6/5/2020
Quarterly Report for period ending 2020-03-31
10-Q
Monday, 5/11/2020
Quarterly Report for period ending 2020-03-31
10-K
Monday, 3/16/2020
Annual Report for period ending 2019-12-31
10-Q
Tuesday, 11/12/2019
Quarterly Report for period ending 2019-09-30
10-Q
Tuesday, 8/13/2019
Quarterly Report for period ending 2019-06-30
10-Q
Tuesday, 5/14/2019
Quarterly Report for period ending 2019-03-31
10-K
Monday, 4/1/2019
Annual Report for period ending 2018-12-31
10-Q
Monday, 12/3/2018
Quarterly Report for period ending 2018-09-30
News (53)
8-K
Wednesday, 11/16/2022
Current report filing
8-K
Monday, 11/14/2022
Current report filing
8-K
Thursday, 10/20/2022
Current report filing
8-K
Friday, 10/7/2022
Current report filing
8-K
Monday, 10/3/2022
Current report filing
8-K
Friday, 9/23/2022
Current report filing
8-K
Tuesday, 9/20/2022
Current report filing
8-K
Friday, 9/16/2022
Current report filing
8-K
Monday, 8/15/2022
Current report filing
8-K
Tuesday, 6/21/2022
Current report filing
8-K
Monday, 5/16/2022
Current report filing
8-K/A
Friday, 3/18/2022
Current report filing
8-K
Friday, 3/18/2022
Current report filing
8-K
Friday, 3/4/2022
Current report filing
8-K
Wednesday, 2/2/2022
Current report filing
8-K
Wednesday, 12/22/2021
Current report filing
8-K
Monday, 11/15/2021
Current report filing
8-K
Monday, 10/18/2021
Current report filing
8-K
Monday, 8/9/2021
Current report filing
8-K
Tuesday, 6/15/2021
Current report filing
8-K
Wednesday, 6/2/2021
Current report filing
8-K
Monday, 5/10/2021
Current report filing
8-K
Thursday, 4/29/2021
Current report filing
8-K
Monday, 3/15/2021
Current report filing
8-K
Tuesday, 1/12/2021
Current report filing
8-K
Tuesday, 12/22/2020
Current report filing
8-K
Monday, 12/14/2020
Current report filing
8-K
Monday, 11/9/2020
Current report filing
8-K
Tuesday, 11/3/2020
Current report filing
8-K
Monday, 10/5/2020
Current report filing
8-K
Wednesday, 9/30/2020
Current report filing
8-K
Monday, 8/10/2020
Current report filing
8-K
Thursday, 6/25/2020
Current report filing
8-K
Wednesday, 6/17/2020
Current report filing
8-K
Monday, 5/11/2020
Current report filing
8-K
Friday, 3/20/2020
Current report filing
8-K
Monday, 3/16/2020
Current report filing
8-K
Monday, 2/10/2020
Current report filing
8-K
Friday, 1/10/2020
Current report filing
8-K
Tuesday, 11/12/2019
Current report filing
8-K
Friday, 11/8/2019
Current report filing
8-K
Tuesday, 8/13/2019
Current report filing
8-K
Tuesday, 7/2/2019
Current report filing
8-K
Thursday, 6/27/2019
Current report filing
8-K
Monday, 6/24/2019
Current report filing
8-K
Tuesday, 5/14/2019
Current report filing
8-K
Thursday, 4/18/2019
Current report filing
8-K
Friday, 4/12/2019
Current report filing
8-K
Monday, 4/1/2019
Current report filing
8-K
Thursday, 2/28/2019
Current report filing
8-K
Thursday, 12/20/2018
Current report filing
8-K
Monday, 12/3/2018
Current report filing
8-K
Monday, 10/29/2018
Current report filing
Other (25)
15-12G
Tuesday, 11/29/2022
Notice of termination of registration of a class of securities under Section 12(g)
EFFECT
Friday, 11/18/2022
Notice of Effectiveness
SC 14D9/A
Wednesday, 11/16/2022
Tender offer solicitation/recommendation statements filed under Rule 14d-9
25-NSE
Wednesday, 11/16/2022
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
POS AM
Wednesday, 11/16/2022
Post-effective amendment to a registration statement that is not immediately effective upon filing
SC 14D9
Tuesday, 10/18/2022
Tender offer solicitation/recommendation statements filed under Rule 14d-9
SC14D9C
Monday, 10/3/2022
Written communication by the subject company relating to a third party tender offer
CT ORDER
Wednesday, 3/23/2022
Order Granting Confidential Treatment
CT ORDER
Friday, 7/16/2021
Order Granting Confidential Treatment
SEC STAFF LETTER
Monday, 4/19/2021
None
SEC STAFF LETTER
Monday, 3/22/2021
None
CORRESP
Friday, 6/5/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Monday, 11/25/2019
Notice of Effectiveness
CORRESP
Thursday, 11/21/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CT ORDER
Friday, 4/26/2019
Order Granting Confidential Treatment
POS EX
Friday, 10/19/2018
Post-effective amendment filed solely to add exhibits to a registration statement
CERT
Thursday, 10/18/2018
Certification by an exchange approving securities for listing
CT ORDER
Thursday, 10/18/2018
Order Granting Confidential Treatment
EFFECT
Thursday, 10/18/2018
Notice of Effectiveness
8-A12B
Wednesday, 10/17/2018
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Tuesday, 10/16/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 10/16/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 10/2/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Wednesday, 7/5/2017
Exempt (Private) Offering
D
Thursday, 1/21/2016
Exempt (Private) Offering
Ownership (157)
SC 13G/A
Tuesday, 2/14/2023
Beryl Capital Management LLC: Major Shareholders
SC 13D/A
Friday, 2/10/2023
Arix Bioscience plc: Major Shareholders
4
Thursday, 11/17/2022
WYZGA MICHAEL S: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Karydas Daphne: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
MOSCICKI RICHARD A: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Enyedy Mark J: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Gruskin Daniel: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Goater Jeff: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Kahn Susan: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Chen Leon: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Nacht Mariana: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Kay Mark A: Statement of changes in beneficial ownership of securities
4
Thursday, 11/17/2022
Chereau Frederic: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 10/20/2022
Andera Partners: Major Shareholders
SC 13G
Thursday, 10/13/2022
Beryl Capital Management LLC: Major Shareholders
3
Friday, 9/30/2022
Blacher Joshua: Initial statement of beneficial ownership of securities
4
Tuesday, 7/5/2022
Karydas Daphne: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Enyedy Mark J: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Kahn Susan: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Chen Leon: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Kay Mark A: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Goater Jeff: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
MOSCICKI RICHARD A: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
WYZGA MICHAEL S: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 5/4/2022
Arix Bioscience plc: Major Shareholders
4
Thursday, 3/3/2022
Nacht Mariana: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Gruskin Daniel: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Jones Cecilia: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Chereau Frederic: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Paul Andrea: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 2/15/2022
Arix Bioscience plc: Major Shareholders
SC 13G/A
Friday, 2/4/2022
FRANKLIN RESOURCES INC: Major Shareholders
4
Thursday, 1/13/2022
Jones Cecilia: Statement of changes in beneficial ownership of securities
3
Thursday, 12/23/2021
Kahn Susan: Initial statement of beneficial ownership of securities
4
Thursday, 12/23/2021
Kahn Susan: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 10/26/2021
Arix Bioscience plc: Major Shareholders
4
Tuesday, 8/10/2021
Gruskin Daniel: Statement of changes in beneficial ownership of securities
4
Monday, 6/21/2021
Kay Mark A: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
Kay Mark A: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
Chen Leon: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
MOSCICKI RICHARD A: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
WYZGA MICHAEL S: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
Karydas Daphne: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
Enyedy Mark J: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
Goater Jeff: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Gruskin Daniel: Statement of changes in beneficial ownership of securities
3
Thursday, 5/20/2021
Gruskin Daniel: Initial statement of beneficial ownership of securities
4
Wednesday, 5/19/2021
Paul Andrea: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/19/2021
Paul Andrea: Initial statement of beneficial ownership of securities
4
Monday, 4/19/2021
Chereau Frederic: Statement of changes in beneficial ownership of securities
4
Monday, 4/19/2021
Chiang Kyle: Statement of changes in beneficial ownership of securities
4
Thursday, 2/25/2021
Chereau Frederic: Statement of changes in beneficial ownership of securities
4
Thursday, 2/25/2021
Chiang Kyle: Statement of changes in beneficial ownership of securities
4
Thursday, 2/25/2021
Jones Cecilia: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/16/2021
Nussbaum Ran: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Andera Partners: Major Shareholders
SC 13G/A
Thursday, 2/11/2021
ADAGE CAPITAL PARTNERS GP, L.L.C.: Major Shareholders
SC 13G/A
Thursday, 2/11/2021
Nussbaum Ran: Major Shareholders
SC 13G
Monday, 2/1/2021
FRANKLIN RESOURCES INC: Major Shareholders
3
Wednesday, 1/13/2021
Jones Cecilia: Initial statement of beneficial ownership of securities
4
Wednesday, 1/13/2021
Jones Cecilia: Statement of changes in beneficial ownership of securities
3
Friday, 1/8/2021
Quick Jonathan: Initial statement of beneficial ownership of securities
4
Monday, 1/4/2021
Chen Leon: Statement of changes in beneficial ownership of securities
4
Monday, 1/4/2021
Enyedy Mark J: Statement of changes in beneficial ownership of securities
4
Monday, 1/4/2021
MOSCICKI RICHARD A: Statement of changes in beneficial ownership of securities
4
Monday, 1/4/2021
WYZGA MICHAEL S: Statement of changes in beneficial ownership of securities
4
Monday, 1/4/2021
Kay Mark A: Statement of changes in beneficial ownership of securities
3
Monday, 12/14/2020
Karydas Daphne: Initial statement of beneficial ownership of securities
4
Monday, 12/14/2020
Goater Jeff: Statement of changes in beneficial ownership of securities
4
Monday, 12/14/2020
O'Connell Daniel P: Statement of changes in beneficial ownership of securities
3
Monday, 12/14/2020
Goater Jeff: Initial statement of beneficial ownership of securities
4
Monday, 12/14/2020
Karydas Daphne: Statement of changes in beneficial ownership of securities
3
Tuesday, 12/1/2020
Nacht Mariana: Initial statement of beneficial ownership of securities
4
Tuesday, 12/1/2020
Nacht Mariana: Statement of changes in beneficial ownership of securities
4
Thursday, 11/12/2020
Chiang Kyle: Statement of changes in beneficial ownership of securities
3
Thursday, 11/12/2020
Chiang Kyle: Initial statement of beneficial ownership of securities
SC 13D/A
Tuesday, 10/6/2020
ORBIMED ADVISORS LLC: Major Shareholders
4
Monday, 10/5/2020
Chimovits Erez: Statement of changes in beneficial ownership of securities
4
Monday, 10/5/2020
Arix Bioscience plc: Statement of changes in beneficial ownership of securities
4
Monday, 10/5/2020
ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 9/29/2020
Arix Bioscience plc: Major Shareholders
4
Tuesday, 6/23/2020
Chen Leon: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/23/2020
Enyedy Mark J: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/23/2020
MOSCICKI RICHARD A: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/23/2020
O'Connell Daniel P: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/23/2020
Chimovits Erez: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/23/2020
WYZGA MICHAEL S: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/23/2020
Kay Mark A: Statement of changes in beneficial ownership of securities
4
Friday, 4/17/2020
Yoon Seokho Bryan: Statement of changes in beneficial ownership of securities
4
Friday, 4/17/2020
Jaffe Matthias: Statement of changes in beneficial ownership of securities
4
Friday, 4/17/2020
Chereau Frederic: Statement of changes in beneficial ownership of securities
4
Thursday, 3/19/2020
Enyedy Mark J: Statement of changes in beneficial ownership of securities
3
Thursday, 3/19/2020
Enyedy Mark J: Initial statement of beneficial ownership of securities
SC 13G/A
Friday, 2/21/2020
Barzel Adi: Major Shareholders
SC 13G
Friday, 2/14/2020
Nussbaum Ran: Major Shareholders
4
Thursday, 2/13/2020
Chereau Frederic: Statement of changes in beneficial ownership of securities
4
Thursday, 2/13/2020
Yoon Seokho Bryan: Statement of changes in beneficial ownership of securities
4
Thursday, 2/13/2020
Huttner Kenneth: Statement of changes in beneficial ownership of securities
4
Thursday, 2/13/2020
Jaffe Matthias: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 2/12/2020
ADAGE CAPITAL PARTNERS GP, L.L.C.: Major Shareholders
Prospectus (22)
SC TO-T/A
Wednesday, 11/16/2022
Third party tender offer statement
S-8 POS
Wednesday, 11/16/2022
Post-effective amendment to a S-8 registration statement
S-8 POS
Wednesday, 11/16/2022
Post-effective amendment to a S-8 registration statement
S-8 POS
Wednesday, 11/16/2022
Post-effective amendment to a S-8 registration statement
S-8 POS
Wednesday, 11/16/2022
Post-effective amendment to a S-8 registration statement
SC TO-T
Tuesday, 10/18/2022
Third party tender offer statement
SC TO-C
Monday, 10/3/2022
Written communication relating to an issuer or third party tender offer
S-8
Monday, 5/16/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Monday, 3/15/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Friday, 10/2/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 9/30/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Tuesday, 3/17/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3
Friday, 11/15/2019
Registration statement for specified transactions by certain issuers
S-8
Tuesday, 4/2/2019
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Monday, 10/22/2018
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Wednesday, 10/17/2018
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Thursday, 10/11/2018
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 10/9/2018
General form of registration statement for all companies including face-amount certificate companies
S-1
Tuesday, 9/25/2018
General form of registration statement for all companies including face-amount certificate companies
DRS/A
Friday, 9/21/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Thursday, 9/20/2018
Correspondence Related to Draft Registration Statement
DRS
Monday, 8/13/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (9)
DEF 14A
Friday, 4/29/2022
Definitive proxy statements
DEFA14A
Friday, 4/29/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Tuesday, 4/27/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Tuesday, 4/27/2021
Definitive proxy statements
DEFA14A
Friday, 6/5/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Wednesday, 4/29/2020
Definitive proxy statements
DEFA14A
Wednesday, 4/29/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Monday, 4/29/2019
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Monday, 4/29/2019
Definitive proxy statements